Rhythm Biosciences Limited Price (RHY.AX)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

228,296,917

(3.0492)%

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

Rhythm Biosciences Limited, a transformative predictive cancer diagnostics technology company in Australia and internationally. The company engages in developing and commercializing medical diagnostics technology. It develops ColoSTAT, a blood test for the early detection of colorectal cancer. The company was incorporated in 2017 and is headquartered in Parkville, Australia. Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $0.042-0.14
  • Market Cap 24.37M
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Medical - Diagnostics & Research

  • ceo: Dr. David Atkins M.B.A., Ph.D.
  • IPO Date: December, 06, 2017
  • Country: AU
  • Currency: AUD
  • Headquaters: Parkville, VIC
  • Employees: No Data

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation